Chimeric Therapeutics Competitors and Similar CompaniesClear all
Spur Therapeutics's competitors and similar companies include Cellares and Polyplus-transfection.
 Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. | ||
Founding Date | Founding Date 2015 | Founding Date 2019 | Founding Date 2002 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Stevenage, GB HQ Boston, US New York, US | Locations South San Francisco, US HQ | Locations Illkirch-Graffenstaden, FR HQ New York, US |
Employees | Employees 122 | Employees 2613% increase | Employees 1133% increase |
Funding | |||
Total funding raised | Total funding raised $ 289.3m | Total funding raised N/A | Total funding raised $ 3.2m |
For sources of this data, please see the company profile
View Company Profiles
Cellares
HQ
South San Francisco, US
Employees
261↑ 3% increase
Cellares is a provider of cell therapy manufacturing services.
View companyPolyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View company